Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2447 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 48.72 USD | +1.52% | +2.85% | +3.99% | +61.70% | 910.08 M USD | ||
| 2454 |  ALMS Alumis Inc. - Common Stock | 6.97 USD | +2.95% | -1.97% | -33.30% | +54.55% | 902.16 M USD | ||
| 2459 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 10.58 USD | -1.76% | -9.11% | -28.99% | +10.67% | 900.43 M USD | ||
| 2462 |  JBIO Jade Biosciences, Inc. - Common Stock | 14.15 USD | +2.76% | +2.09% | -27.17% | +40.80% | 899.90 M USD | ||
| 2474 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 10.32 USD | +1.47% | -9.47% | -27.73% | -8.67% | 880.43 M USD | ||
| 2489 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 10.21 USD | -1.92% | -8.10% | -21.82% | +41.02% | 858.87 M USD | ||
| 2513 |  SANA Sana Biotechnology, Inc. - Common Stock | 2.79 USD | +2.57% | -5.42% | -10.00% | -38.00% | 835.22 M USD | ||
| 2519 |  ABUS Arbutus Biopharma Corporation - Common Stock | 4.18 USD | -2.56% | -8.13% | -18.20% | -2.11% | 827.00 M USD | ||
| 2524 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 16.71 USD | -1.07% | -42.89% | -43.05% | -20.73% | 823.93 M USD | ||
| 2532 |  ARDX Ardelyx, Inc. - Common Stock | 3.27 USD | +0.31% | -3.25% | -13.03% | -35.25% | 814.84 M USD | ||
| 2559 |  GERN Geron Corporation - Common Stock | 1.22 USD | +1.67% | +0.83% | -12.86% | -13.48% | 783.82 M USD | ||
| 2562 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.76 USD | 0.00% | -4.86% | -16.59% | +6.02% | 783.12 M USD | ||
| 2583 |  ANNX Annexon, Inc. - common stock | 4.00 USD | -0.25% | -4.08% | -5.88% | +22.70% | 758.32 M USD | ||
| 2586 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.76 USD | -3.98% | -4.65% | -5.72% | -18.16% | 753.81 M USD | ||
| 2598 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 7.19 USD | -0.69% | -5.64% | -3.62% | +119.21% | 739.87 M USD | ||
| 2599 |  CADL Candel Therapeutics, Inc. - Common Stock | 9.66 USD | -1.63% | -6.12% | -19.70% | +46.59% | 739.17 M USD | ||
| 2601 |  VSTM Verastem, Inc. - Common Stock | 8.11 USD | -1.93% | +2.01% | +2.53% | -12.51% | 734.47 M USD | ||
| 2605 |  SLDB Solid Biosciences Inc. - Common Stock | 6.82 USD | -0.44% | -6.06% | -30.19% | +19.65% | 731.28 M USD | ||
| 2606 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 11.36 USD | -0.87% | -11.87% | +66.08% | +27.93% | 730.91 M USD | ||
| 2617 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 13.43 USD | -1.10% | -11.41% | -25.06% | -8.76% | 720.25 M USD |
Notizie Biotechnology Stocks
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
AbCellera presenterà dati di fase 1/2 sul farmaco per la menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |